Cargando…
Challenges in the clinical advancement of cell therapies for Parkinson’s disease
Cell therapies as potential treatments for Parkinson’s disease first gained traction in the 1980s, owing to the clinical success of trials that used transplants of foetal midbrain dopaminergic tissue. However, the poor standardization of the tissue for grafting, and constraints on its availability a...
Autores principales: | Skidmore, Sophie, Baker, Roger A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615223/ https://www.ncbi.nlm.nih.gov/pubmed/36635420 http://dx.doi.org/10.1038/s41551-022-00987-y |
Ejemplares similares
-
Cell replacement for Parkinson’s disease: advances and challenges
por: Xiao, Bin, et al.
Publicado: (2023) -
Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective
por: Barker, Roger A., et al.
Publicado: (2021) -
Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Patient’s Perspective
por: Mathur, Soania, et al.
Publicado: (2021) -
Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Scientist’s Perspective
por: Tomishima, Mark, et al.
Publicado: (2021) -
Treatment of Advanced Parkinson's Disease
por: Varanese, Sara, et al.
Publicado: (2011)